Literature DB >> 25275020

STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides.

Simon Fredholm1, Lise Mette R Gjerdrum2, Andreas Willerslev-Olsen1, David L Petersen1, Inger Ø Nielsen1, Claudia-S Kauczok3, Marion Wobser3, Ulrik Ralfkiaer1, Charlotte M Bonefeld1, Mariusz A Wasik4, Thorbjørn Krejsgaard1, Carsten Geisler1, Elisabeth Ralfkiaer2, Robert Gniadecki5, Anders Woetmann1, Niels Odum6.   

Abstract

Eosinophil granulocytes have been implicated in anticancer immunity but recent data indicate that eosinophils can also promote cancer. Herein, we studied eosinophils in skin lesions from 43 patients with mycosis fungoides (MF). The presence of eosinophils correlated with disease stage: 78% of patients with advanced disease displayed eosinophil infiltration, whereas this was only seen in 11% of patients with patches (p<0.01), and in 48% of those with plaque disease. Importantly, 72% of patients with positive staining for phospho-signal-transducer-and-activator-of-transcription (pY-STAT3) in malignant T-cells also stained positively for eosinophils, whereas this was only observed in 28% of pY-STAT3-negative patients (p<0.01). Notably, malignant T-cells expressed eosinophilic activation and trafficking factors: High-mobility group BOX-1 protein (HMGB1) and interleukin 5 (IL5). STAT3 siRNA profoundly inhibited IL5 but not HMGB1 expression. In conclusion, these data suggest that malignant T-cells orchestrate accumulation and activation of eosinophils supporting the notion of STAT3 being a putative target for therapy. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  CTCL; Cutaneous T-cell lymphoma; HMGB1; IL5; STAT3; eosinophils; high-mobility group protein B1; interleukin-5

Mesh:

Substances:

Year:  2014        PMID: 25275020

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Fulminant Mycosis Fungoides with Tissue Eosinophilia: A Unique Presentation of Two Cases with Acro-Periorbital Ulceration and An Aggressive Clinical Course.

Authors:  David R Pearson; Mayumi Fujita; Whitney A High
Journal:  J Mol Biomark Diagn       Date:  2017-03-02

Review 2.  Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.

Authors:  Thorbjørn Krejsgaard; Lise M Lindahl; Nigel P Mongan; Mariusz A Wasik; Ivan V Litvinov; Lars Iversen; Erik Langhoff; Anders Woetmann; Niels Odum
Journal:  Semin Immunopathol       Date:  2016-10-07       Impact factor: 9.623

Review 3.  High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.

Authors:  Shunling Yuan; Zhaoping Liu; Zhenru Xu; Jing Liu; Ji Zhang
Journal:  J Hematol Oncol       Date:  2020-07-13       Impact factor: 17.388

4.  Human P2Y11 Expression Level Affects Human P2X7 Receptor-Mediated Cell Death.

Authors:  Karin Dreisig; Louise Sund; Maja Wallentin Dommer; Nikolaj Pagh Kristensen; Kim Boddum; Rannveig Viste; Simon Fredholm; Niels Odum; Marja Jäättelä; Søren Skov; Birgitte R Kornum
Journal:  Front Immunol       Date:  2018-06-08       Impact factor: 7.561

Review 5.  Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome.

Authors:  Andrea Moerman-Herzog; Syed J Mehdi; Henry K Wong
Journal:  Cells       Date:  2020-08-29       Impact factor: 6.600

Review 6.  The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome.

Authors:  Denis Miyashiro; Bruno de Castro E Souza; Marina Passos Torrealba; Kelly Cristina Gomes Manfrere; Maria Notomi Sato; José Antonio Sanches
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.